Drug repurposing for coronavirus (COVID-19): <i>in silico</i> screening of known drugs against coronavirus 3CL hydrolase and protease enzymes

  • Ammar D. Elmezayen
    Department of Bioinformatics and Genetics, Faculty of Engineering and Natural Sciences, Kadir Has University, Istanbul, Turkey
  • Anas Al-Obaidi
    Department of Bioinformatics and Genetics, Faculty of Engineering and Natural Sciences, Kadir Has University, Istanbul, Turkey
  • Alp Tegin Şahin
    Department of Bioinformatics and Genetics, Faculty of Engineering and Natural Sciences, Kadir Has University, Istanbul, Turkey
  • Kemal Yelekçi
    Department of Bioinformatics and Genetics, Faculty of Engineering and Natural Sciences, Kadir Has University, Istanbul, Turkey

この論文をさがす

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ